Cargando…
Lung adenocarcinoma patients with novel ALK fusion variants and their clinical responses to ALK inhibitors
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7896746/ https://www.ncbi.nlm.nih.gov/pubmed/33434380 http://dx.doi.org/10.1002/cac2.12128 |
| _version_ | 1783653602122792960 |
|---|---|
| author | Yang, Dafu Li, Dan Dai, Zhaoxia Ma, Yutong Ou, Qiuxiang Wu, Xue Cui, Saiqiong |
| author_facet | Yang, Dafu Li, Dan Dai, Zhaoxia Ma, Yutong Ou, Qiuxiang Wu, Xue Cui, Saiqiong |
| author_sort | Yang, Dafu |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7896746 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78967462021-03-03 Lung adenocarcinoma patients with novel ALK fusion variants and their clinical responses to ALK inhibitors Yang, Dafu Li, Dan Dai, Zhaoxia Ma, Yutong Ou, Qiuxiang Wu, Xue Cui, Saiqiong Cancer Commun (Lond) Letters to the Editor John Wiley and Sons Inc. 2021-01-12 /pmc/articles/PMC7896746/ /pubmed/33434380 http://dx.doi.org/10.1002/cac2.12128 Text en © 2020 The Authors. Cancer Communications published by John Wiley & Sons Australia, Ltd. on behalf of Sun Yat‐sen University Cancer Center This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Letters to the Editor Yang, Dafu Li, Dan Dai, Zhaoxia Ma, Yutong Ou, Qiuxiang Wu, Xue Cui, Saiqiong Lung adenocarcinoma patients with novel ALK fusion variants and their clinical responses to ALK inhibitors |
| title | Lung adenocarcinoma patients with novel ALK fusion variants and their clinical responses to ALK inhibitors |
| title_full | Lung adenocarcinoma patients with novel ALK fusion variants and their clinical responses to ALK inhibitors |
| title_fullStr | Lung adenocarcinoma patients with novel ALK fusion variants and their clinical responses to ALK inhibitors |
| title_full_unstemmed | Lung adenocarcinoma patients with novel ALK fusion variants and their clinical responses to ALK inhibitors |
| title_short | Lung adenocarcinoma patients with novel ALK fusion variants and their clinical responses to ALK inhibitors |
| title_sort | lung adenocarcinoma patients with novel alk fusion variants and their clinical responses to alk inhibitors |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7896746/ https://www.ncbi.nlm.nih.gov/pubmed/33434380 http://dx.doi.org/10.1002/cac2.12128 |
| work_keys_str_mv | AT yangdafu lungadenocarcinomapatientswithnovelalkfusionvariantsandtheirclinicalresponsestoalkinhibitors AT lidan lungadenocarcinomapatientswithnovelalkfusionvariantsandtheirclinicalresponsestoalkinhibitors AT daizhaoxia lungadenocarcinomapatientswithnovelalkfusionvariantsandtheirclinicalresponsestoalkinhibitors AT mayutong lungadenocarcinomapatientswithnovelalkfusionvariantsandtheirclinicalresponsestoalkinhibitors AT ouqiuxiang lungadenocarcinomapatientswithnovelalkfusionvariantsandtheirclinicalresponsestoalkinhibitors AT wuxue lungadenocarcinomapatientswithnovelalkfusionvariantsandtheirclinicalresponsestoalkinhibitors AT cuisaiqiong lungadenocarcinomapatientswithnovelalkfusionvariantsandtheirclinicalresponsestoalkinhibitors |